Biogen to present Alzheimer's data at CTAD conference in November
Tweet Send to a Friend
Biogen Inc. (Nasdaq: BIIB) announced it will present new data from its Alzheimer's disease portfolio at the 19th Clinical Trials ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




